Skip to content

Effectiveness of Percutane Tibiale Nerve Stimulation (PTNS) treatment in children

Effectiveness of Percutane Tibiale Nerve Stimulation (PTNS) treatment in children - Ped-PTNS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43544
Enrollment
20
Registered
2017-01-10
Start date
2017-03-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder overactivity urinary incontinence

Interventions

during 12 weeks , participants come for 30 minutes for the nerve tiblialis stimulation.

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: * age >8 en

Exclusion criteria

Exclusion criteria: - congenitale urological anomalies, except for mild urethral valves and meatus operation (asessed by pediatric urologist) -voiding problems due to neurogenic case -continuing of anticholinergics - untreated or inadequatly treated obstipation -pacemaker or implanted defibrillator -Prone to excessive bleeding -Pregnancy -previous PTNS treatment -previous botuline toxine intravesical treatment for overactive bladder within 6 months of the start of the study

Design outcomes

Primary

MeasureTime frame
Outcome and differences in parameters measured on Frequency-volume charts: urgency, average bladder capacity, diaper weight, micturation frequency day/night, severity of incontinence. All parameters are measured at basline, after 12 weeks and after 16 weeks and compared

Secondary

MeasureTime frame
Outcome and differences in quality of life scores at baseline, 12 weeks and 16 weeks

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)